Fig. 11From: A real-world study and network pharmacology analysis of EGFR-TKIs combined with ZLJT to delay drug resistance in advanced lung adenocarcinoma| Visualization of the binding models. A Luteolin and FOS (-9.8Â kcal/mol). B Tanshinone IIA and FOS (-9.8Â kcal/mol). C Quercetin and FOS (-8.7Â kcal/mol)Back to article page